insights_auto
Why is BOT down ९.०९%?
Dive Deeperchevron_right
BOT:ASX
Botanix Pharmaceuticals Ltd
A$ ०.०१०
arrow_downward
-९.०९%(-०.००१०) 1D
नोभेम्बर ६, १६:१०:२८ GMT+११ · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BOT...
Open
A$ ०.०१
High
A$ ०.०१
Low
A$ ०.०१
Mkt. cap
३.०४ करोड
Avg. vol.
९२.०३ लाख
Volume
२.३७ करोड
52-wk high
A$ ०.१५
52-wk low
A$ ०.०१
EPS
-A$ ०.०३
Shares outstanding
२.७६ अरब
No. of employees
११
Open
A$ ०.०१
High
A$ ०.०१
Low
A$ ०.०१
Mkt. cap
३.०४ करोड
Avg. vol.
९२.०३ लाख
Volume
२.३७ करोड
52-wk high
A$ ०.१५
52-wk low
A$ ०.०१
EPS
-A$ ०.०३
Shares outstanding
२.७६ अरब
No. of employees
११
News stories
From web sources and news partners
Finviz
·
१ घण्टा पहिले
PSQ Holdings Shrinks Losses And Cash Burn, But Slowing Growth, A Steep Q4 Target And NYSE Listing Risk Define The Setup
Reuters Connect
·
२ घण्टा पहिले
Traders work on the floor of the NYSE in New York
Central Oregon Daily
·
७ मिनेट पहिले
Nasdaq rebounds but remains on track for fourth straight weekly decline
Profile
Botanix Pharmaceuticals is listed on the Australian Securities Exchange with the issue code BOT. The Company is headquartered in Perth, Western Australia and Philadelphia, USA. It is a clinical stage synthetic cannabinoid company, focusing on the compound Cannabidiol. The company's lead product is Sofdra, which treats axillary hyperhidrosis. The company has two separate development platforms, dermatology and antimicrobial. Botanix also has an exclusive license to use a proprietary drug delivery system Permetrex, for direct skin delivery of active pharmaceuticals which is utilised in all of their programs. Wikipedia
About Botanix Pharmaceuticals Ltd